Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
PCNA and dyslipidemia are reported together in 1 article.
Gene
PCNA
- HGNC
- HGNC:8729
92articles
92mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype
Dyslipidemia
338articles
338mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
1 records shown · first 60Comparative study of obeticholic acid and rosuvastatin in high-fat/fructose diet-induced metabolic dysfunction: role of AMPK, PPAR-γ, SREBP-1c, and STAT3 pathways.
PMID 41559213 | DOI 10.1007/s10735-025-10668-0 · Journal of molecular histology · 2026 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | PCNA | “In addition to Liver and adipose tissue histopathology, area percentage of collagen fibers, adipocytes diameter, PPAR-γ, STAT3 and PCNA immunoexpression.” | 0.98 | hgnc_dict_v1 |
| phenotype | dyslipidemia | “Metabolic syndrome (MetS), often modeled by high-fat/fructose (HFF) diets, involves dyslipidemia, hypertension, insulin resistance, and liver dysfunction.” | 0.98 | phenotype_alias_lexicon_v2 |
| gene | STAT3 | “Comparative study of obeticholic acid and rosuvastatin in high-fat/fructose diet-induced metabolic dysfunction: role of AMPK, PPAR-γ, SREBP-1c, and STAT3 pathways.” | 0.98 | hgnc_dict_v1 |
| phenotype | hypertension | “Metabolic syndrome (MetS), often modeled by high-fat/fructose (HFF) diets, involves dyslipidemia, hypertension, insulin resistance, and liver dysfunction.” | 0.98 | phenotype_alias_lexicon_v2 |